At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
07666 METIS TECHBIO-P
Noon Closed 07-14 11:59:54
10.500
-0.440
-4.02%
High11.010Low9.720Vol1.27M
Open10.750D1 Closing10.940Amplitude11.79%
Mkt Cap12.42BTradable Cap11.37BTotal Shares1.18B
T/O12.91MT/O Rate0.12%Tradable Shares1.08B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Metis TechBio Reports 2.9% Expansion in H-Share Base Following Full Exercise of Over-Allotment Option
Bulletin Express  ·  07-06
Metis TechBio Reports 2.9% Expansion in H-Share Base Following Full Exercise of Over-Allotment Option
METIS TECHBIO-P Surges Over 6% in Early Trading Following $1.6 Billion Preclinical TCE Licensing Deal
Deep News  ·  07-03
METIS TECHBIO-P Surges Over 6% in Early Trading Following $1.6 Billion Preclinical TCE Licensing Deal
Metis Techbio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager
THOMSON REUTERS  ·  06-30
Metis Techbio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager
Hk-listed Metis Techbio Climbs on Boulevard Bio Tie-up
Reuters  ·  06-30
Hk-listed Metis Techbio Climbs on Boulevard Bio Tie-up
Metis Techbio Signs Global Licensing Deal for Biologic Drug Worth up to $1.6 Billion
Reuters  ·  06-30
Metis Techbio Signs Global Licensing Deal for Biologic Drug Worth up to $1.6 Billion
Metis Techbio Licenses Trispecific TCE Mts-128 to Deerfield’s Boulevard Bio in Deal Worth up to USD 1.6 Billion
Reuters  ·  06-30
Metis Techbio Licenses Trispecific TCE Mts-128 to Deerfield’s Boulevard Bio in Deal Worth up to USD 1.6 Billion
Metis Techbio Co - to Receive $20 Mln Upfront and up to $1.6 Bln in Milestone Payments
THOMSON REUTERS  ·  06-30
Metis Techbio Co - to Receive $20 Mln Upfront and up to $1.6 Bln in Milestone Payments
Metis Techbio Co Ltd - Announces a Preclinical Tce Licensing Collaboration with Deerfield of up to Us$1.6 Bln
THOMSON REUTERS  ·  06-30
Metis Techbio Co Ltd - Announces a Preclinical Tce Licensing Collaboration with Deerfield of up to Us$1.6 Bln
Metis TechBio-P Shares Surge Over 10% as AI Drug Discovery Sector Enters Validation Phase
Stock News  ·  06-29
Metis TechBio-P Shares Surge Over 10% as AI Drug Discovery Sector Enters Validation Phase
METIS TECHBIO-P Shares Surge Over 8% in Early Trading on STAR Market AI Expansion and Strategic Alliance News
Stock News  ·  06-23
METIS TECHBIO-P Shares Surge Over 8% in Early Trading on STAR Market AI Expansion and Strategic Alliance News
Metis TechBio Rolls Out Fully Digital Distribution of Corporate Communications
Bulletin Express  ·  06-22
Metis TechBio Rolls Out Fully Digital Distribution of Corporate Communications
METIS TECHBIO-P Surges Again, Up Over 20% in Five Sessions Following AI Drug Development Alliance
Stock News  ·  06-17
METIS TECHBIO-P Surges Again, Up Over 20% in Five Sessions Following AI Drug Development Alliance
METIS TECHBIO-P Shares Surge Over 7% in Morning Session on Strategic Alliance News
Stock News  ·  06-15
METIS TECHBIO-P Shares Surge Over 7% in Morning Session on Strategic Alliance News
Metis TechBio Updates Company Secretary Structure and Obtains Continued Waiver on HKEX Compliance
Bulletin Express  ·  06-12
Metis TechBio Updates Company Secretary Structure and Obtains Continued Waiver on HKEX Compliance
METIS TECHBIO-P Announces Appointment of Chen Xi as Joint Company Secretary and Authorized Representative
Stock News  ·  06-12
METIS TECHBIO-P Announces Appointment of Chen Xi as Joint Company Secretary and Authorized Representative
Metis TechBio appoints Chan Hei as joint company secretary, authorized representative as Cheng Yuk Ting exits
Reuters  ·  06-12
Metis TechBio appoints Chan Hei as joint company secretary, authorized representative as Cheng Yuk Ting exits
METIS TECHBIO-P Shares Surge Up to 7% Following Launch of AiProtein Platform and AARON AI Agent
Stock News  ·  06-12
METIS TECHBIO-P Shares Surge Up to 7% Following Launch of AiProtein Platform and AARON AI Agent
Movement Alert｜METiS Pharmaceuticals-P Falls 5.26% in Regular Trading, Over-Allotment Shares Begin Trading Intensifying Selling Pressure
Market Focus  ·  06-11
Movement Alert｜METiS Pharmaceuticals-P Falls 5.26% in Regular Trading, Over-Allotment Shares Begin Trading Intensifying Selling Pressure
Metis TechBio issues 30.18 million new H-shares after full exercise of over-allotment option
Bulletin Express  ·  06-10
Metis TechBio issues 30.18 million new H-shares after full exercise of over-allotment option
METIS TECHBIO-P Issues 30.184 Million Shares Following Full Exercise of Over-Allotment Option
Stock News  ·  06-10
METIS TECHBIO-P Issues 30.184 Million Shares Following Full Exercise of Over-Allotment Option

Introduction

Company Name.
METIS TECHBIO-P
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Metis TechBio Co Ltd is a China-based company mainly engaged in innovation of artificial intelligence (AI) nanomaterials. NanoForge is the foundation of the Company's AI-driven nanotechnology innovation system, including de novo lipid library, AI foundational models, METiSAIAgent, quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. The Company has developed three specialized solution platforms, including AiTEM, AiLNP, and AiRNA platforms, to simulate, predict, and interpret nanoscale interactions, enabling the rational design, optimization, and validation of advanced nanomaterials and their associated payloads.
Issue price:
--